Evidence map›Paper›PMID 32214116›Full record

ArticleScientific reports2020

Fully Automated Molecular Diagnostic System "Simprova" for Simultaneous Testing of Multiple Items.

Toshihiro Yonekawa, Hidetoshi Watanabe, Norimitsu Hosaka, Shohei Semba, Atsushi Shoji, Masaki Sato, Masato Hamasaki, Shota Yuki, Shiori Sano, Yuji Segawa and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. COVID-19 diagnostics: Molecular biology to nanomaterials.Clinica chimica acta; international journal of clinical chemistry · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Toshihiro YonekawaBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Hidetoshi WatanabeBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Norimitsu HosakaBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Shohei SembaBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Atsushi ShojiBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Masaki SatoBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Masato HamasakiBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Shota YukiBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Shiori SanoBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.
Yuji SegawaBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan. Yuji_Segawa@eiken.co.jp.
Tsugunori NotomiBiochemical Research Laboratory II, Research & Development Division, Eiken Chemical Co., Ltd. 143 Nogi Nogimachi, Shimotsuga-gun, Tochigi, 329-0114, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid amplification-based diagnostics is known as one of the molecular diagnostic systems that allows higher sensitive detection of pathogens than test methods such as immunoassay. However, it has not been widely used because it is complicated to use and takes a long time to generate results. On the other hand, development of fully automated molecular diagnostic systems has been growing around the world as demand for such systems from physicians and laboratory technicians has increased. To meet this demand, we have developed the "Simprova" fully automated molecular diagnostic system, which takes advantage of LAMP (Loop-mediated Isothermal Amplification), a method Eiken Chemical Co., Ltd. invented. Simprova comprises a master unit that controls the entire system and a test unit that extracts and purifies nucleic acid from samples (pretreatment), and uses the LAMP method to detect and amplify nucleic acid. Users can obtain test results automatically by simply installing a pretreatment cartridge, a multi-well testing chip and the sample in the test unit. The multi-well testing chip has 25 reaction wells connected by channels and enables simultaneous testing of multiple targets with one sample. Turnaround time for one test is approximately 30 minutes. Since a conventional extraction and purification method using magnetic-bead separation is used for the pretreatment, nucleic acid can be extracted from serum, plasma, whole blood, urine, and sputum, for example. In addition, the system can perform random-access testing by connecting four test units to the master unit to realize near-the-patient testing. Simprova is therefore a robust and useful system for a wide variety of applications.

Identifiers

PMID32214116
PMCPMC7096461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.